⌘K

Login Start Free

GYRE THERAPEUTICS, INC.·4

Apr 25, 4:01 PM ET

Ye Weiguo 4

4 · GYRE THERAPEUTICS, INC. · Filed Apr 25, 2025

Insider Transaction Report

Form 4

Period: 2025-03-24

GYRE THERAPEUTICS, INC.GYRE

Chief Operating Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2025-03-26−200,000→ 1,165,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (200,000 underlying)
Exercise/Conversion
Common Stock
2025-03-24$0.75/sh+300,000$225,000→ 300,000 total
Exercise/Conversion
Common Stock
2025-03-26$0.75/sh+200,000$150,000→ 500,000 total
Exercise/Conversion
Common Stock
2025-03-27$0.75/sh+150,000$112,500→ 650,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-24−300,000→ 1,365,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (300,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-27−150,000→ 1,015,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]These options are vested in full.

Documents

1 file

4
form4.xmlPrimary
FORM 4